Home | Welcome to Contract Pharma   
Last Updated Saturday, August 23 2014
Print RSS Feed

Search Results for 'Financial Report: Sanofi'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published August 8, 2014
Pharma sales up 7% in the quarter Read More »
Published April 29, 2014
Exchange rates hurt results Read More »
By Gil Roth
Published February 6, 2014
Diabetes, Genzyme, Generics key drivers Read More »
Published October 30, 2013
Product sales up for the first time in five quarters Read More »
Published August 1, 2013
Generic competition, Brazil issue impact results Read More »
Published May 2, 2013
Generic competition continues to hurt revenues Read More »
Published February 7, 2013
Revenues up 3% in the quarter, earnings hurt by generics Read More »
Published October 25, 2012
Genzyme revenues staunch patent losses Read More »
Published April 28, 2011
Lantus sales were up 13% to $1.3 billion in the quarter. Read More »
Published February 10, 2010
Pharmaceutical sales were $9.0 billion (+3%) in 4Q09 and $37.0 billion (+4%) for FY09. Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On